These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32816619)

  • 1. Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease.
    Mitsinikos FT; Chac D; Schillingford N; DePaolo RW
    Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 32816619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
    Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
    Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
    Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Rahman K; Desai C; Iyer SS; Thorn NE; Kumar P; Liu Y; Smith T; Neish AS; Li H; Tan S; Wu P; Liu X; Yu Y; Farris AB; Nusrat A; Parkos CA; Anania FA
    Gastroenterology; 2016 Oct; 151(4):733-746.e12. PubMed ID: 27342212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.
    Zhou D; Pan Q; Shen F; Cao HX; Ding WJ; Chen YW; Fan JG
    Sci Rep; 2017 May; 7(1):1529. PubMed ID: 28484247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
    Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
    Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
    Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.
    Liu L; Fu Q; Li T; Shao K; Zhu X; Cong Y; Zhao X
    PLoS One; 2022; 17(2):e0262855. PubMed ID: 35108315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease.
    Kim H; Worsley O; Yang E; Purbojati RW; Liang AL; Tan W; Moses DID; Hartono S; Fan V; Lim TKH; Schuster SC; Foo RS; Chow PKH; Pettersson S
    Cell Mol Life Sci; 2019 Nov; 76(21):4341-4354. PubMed ID: 31119300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin.
    Li W; Zhang K; Yang H
    J Agric Food Chem; 2018 Aug; 66(30):8015-8025. PubMed ID: 29987933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It's the fiber, not the fat: significant effects of dietary challenge on the gut microbiome.
    Morrison KE; Jašarević E; Howard CD; Bale TL
    Microbiome; 2020 Feb; 8(1):15. PubMed ID: 32046785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary copper-fructose interactions alter gut microbial activity in male rats.
    Song M; Li X; Zhang X; Shi H; Vos MB; Wei X; Wang Y; Gao H; Rouchka EC; Yin X; Zhou Z; Prough RA; Cave MC; McClain CJ
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G119-G130. PubMed ID: 29025734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
    Huang W; Kong D
    Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.
    Zhou Y; Zheng T; Chen H; Li Y; Huang H; Chen W; Du Y; He J; Li Y; Cao J; Nie Y; Zhou Y
    Cell Physiol Biochem; 2018; 51(5):2123-2135. PubMed ID: 30522122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.